Most Popular

A quarterly note from BBCIC Executive Director Cate Lockhart, MS, PharmD, PhD. (July 2023)

A quarterly note from BBCIC Executive Director Cate Lockhart, MS, PharmD, PhD. (April 2024)

A quarterly note from BBCIC Executive Director Cate Lockhart, MS, PharmD, PhD. (December 2023)

A quarterly note from BBCIC Executive Director Cate Lockhart, MS, PharmD, PhD. (October 2023)

A quarterly note from BBCIC Executive Director Cate Lockhart, MS, PharmD, PhD. (June 2023)

A quarterly note from BBCIC Executive Director Cate Lockhart, MS, PharmD, PhD. (March 2023)

The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.

A quarterly note from BBCIC Executive Director Cate Lockhart, MS, PharmD, PhD. (November 2021)

A quarterly note from BBCIC Executive Director Cate Lockhart, MS, PharmD, PhD. (July 2021)